Viewing Study NCT06550895


Ignite Creation Date: 2025-12-24 @ 1:58 PM
Ignite Modification Date: 2026-02-20 @ 2:00 AM
Study NCT ID: NCT06550895
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-05
First Post: 2024-08-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma
Sponsor: Janssen Research & Development, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module